Загрузка...
VEGF neutralizing antibody increases the therapeutic efficacy of vinorelbine for renal cell carcinoma
Renal cell carcinoma (RCC) is currently one of the most treatment-resistant malignancies and affects approximately three in 10,000 people. The impact of this disease produces about 31,000 new cases in the United States per year; and 12,000 people in the United States alone die from RCC annually. Alt...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Blackwell Publishing Ltd
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2992850/ https://ncbi.nlm.nih.gov/pubmed/19017359 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1582-4934.2008.00578.x |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|